FRA
Front Row Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1K | Sell |
27
-18
| -40% | -$733 | ﹤0.01% | 494 |
|
|
2025
Q1 | $1.98K | Hold |
45
| – | – | ﹤0.01% | 448 |
|
|
2024
Q4 | $1.94K | Hold |
45
| – | – | ﹤0.01% | 445 |
|
|
2024
Q3 | $2.01K | Hold |
45
| – | – | ﹤0.01% | 445 |
|
|
2024
Q2 | $1.8K | Hold |
45
| – | – | ﹤0.01% | 859 |
|
|
2024
Q1 | $1.95K | Hold |
45
| – | – | ﹤0.01% | 848 |
|
|
2023
Q4 | $1.88K | Hold |
45
| – | – | ﹤0.01% | 417 |
|
|
2023
Q3 | $1.8K | Hold |
45
| – | – | ﹤0.01% | 822 |
|
|
2023
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 831 |
|
|
2023
Q1 | $2K | Buy |
+45
| New | +$2K | ﹤0.01% | 846 |
|
|
2022
Q4 | – | Sell |
-45
| Closed | -$2K | – | 952 |
|
|
2022
Q3 | $2K | Hold |
45
| – | – | ﹤0.01% | 844 |
|
|
2022
Q2 | $2K | Hold |
45
| – | – | ﹤0.01% | 854 |
|
|
2022
Q1 | $2K | Buy |
45
+1
| +2% | +$44 | ﹤0.01% | 883 |
|
|
2021
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 897 |
|
|
2021
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 891 |
|
|
2021
Q2 | $2K | Hold |
44
| – | – | ﹤0.01% | 894 |
|
|
2021
Q1 | $2K | Hold |
44
| – | – | ﹤0.01% | 889 |
|
|
2020
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 851 |
|
|
2020
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 849 |
|
|
2020
Q2 | $2K | Hold |
44
| – | – | ﹤0.01% | 886 |
|
|
2020
Q1 | $2K | Hold |
44
| – | – | ﹤0.01% | 860 |
|
|
2019
Q4 | $2K | Hold |
44
| – | – | ﹤0.01% | 819 |
|
|
2019
Q3 | $2K | Hold |
44
| – | – | ﹤0.01% | 821 |
|
|
2019
Q2 | $2K | Hold |
44
| – | – | ﹤0.01% | 884 |
|
|
2019
Q1 | $2K | Buy |
+44
| New | +$2K | ﹤0.01% | 883 |
|